ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 64 filers reported holding ONCOCYTE CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $45 | -34.8% | 195 | 0.0% | 0.00% | – |
| Q1 2023 | $69 | +9.5% | 195 | 0.0% | 0.00% | – |
| Q4 2022 | $63 | – | 195 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 195 | -69.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 642 | -15.6% | 0.00% | – |
| Q1 2022 | $1,000 | -92.9% | 761 | -80.7% | 0.00% | -100.0% |
| Q3 2021 | $14,000 | -39.1% | 3,948 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $23,000 | +15.0% | 3,948 | +5.1% | 0.00% | 0.0% |
| Q1 2021 | $20,000 | +566.7% | 3,755 | +1.0% | 0.00% | – |
| Q3 2020 | $3,000 | -57.1% | 3,717 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | -22.2% | 3,717 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $9,000 | +350.0% | 3,717 | +310.7% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 905 | -4.5% | 0.00% | – |
| Q3 2019 | $2,000 | – | 948 | +9380.0% | 0.00% | – |
| Q4 2017 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |